Feldman Liane S, Demyttenaere Sebastian V, Polyhronopoulos Gerry N, Fried Gerald M
Steinberg-Bernstein Centre for Minimally Invasive Surgery, McGill University Health Centre, Montreal, Quebec, Canada.
J Laparoendosc Adv Surg Tech A. 2008 Feb;18(1):13-9. doi: 10.1089/lap.2007.0050.
Although laparoscopic splenectomy is considered the procedure of choice for patients with normal-sized spleens, the benefits are less clear in the presence of splenomegaly, which represents a heterogeneous patient population with a variety of underlying diseases. The aim of this study was to compare the outcomes of laparoscopic (LS) and open splenectomy (OS) for spleens between 15 and 25 cm in length in order to identify strategies for patient selection for the laparoscopic approach.
The medical records of concurrent patients undergoing splenectomy for splenomegaly (>15 cm in the long axis) from 2000 to 2005 were reviewed at two hospitals. At one hospital, LS was performed unless the spleen was >25 cm in length, while the other hospital used OS exclusively. Demographic, intraoperative, and postoperative variables were compared for patients potentially eligible for LS. Data are expressed as median (interquartile range) and were analyzed by using nonparametric tests. A value P < 0.05 was considered statistically significant.
Sixty-five laparoscopic and 25 open splenectomies were performed at the two hospitals, of which 34 were for splenomegaly. Five open cases involved spleens >25 cm and were excluded, leaving 18 LS (13 hand assisted) and 11 OS for further analysis. The groups were similar in comorbidity score, spleen length, hematologic diagnosis, and intraoperative blood loss. The open group was younger, included more females, and had a shorter operative time. Time to oral intake (1 vs. 2 days; P = 0.04) and length of hospital stay (3 vs. 6 days; P = 0.01) were shorter in the LS group. Postoperative complications occurred in 7 (39%) LS and 6 (55%) OS patients (P = 0.47); these were major in 3 LS patients and 1 OS patient (P = 1.0). All 3 major complications after LS occurred in the 3 patients with myelofibrosis and involved a conversion or reoperation by laparotomy for bleeding.
Laparoscopic splenectomy confers benefit for most patients with splenomegaly between 15 and 25 cm, as it is associated with faster time to oral intake and a shorter hospital stay. Major morbidity after laparoscopic splenectomy was mostly related to surgery for myelofibrosis. These patients did not derive any benefit from the laparoscopic approach due to bleeding complications, requiring a conversion or relaparotomy.
尽管腹腔镜脾切除术被认为是脾脏大小正常患者的首选手术方式,但在脾肿大患者中其益处尚不太明确,脾肿大患者群体异质性高,存在多种潜在疾病。本研究的目的是比较腹腔镜(LS)和开放性脾切除术(OS)治疗长度在15至25厘米脾脏的效果,以确定腹腔镜手术患者选择策略。
回顾了2000年至2005年在两家医院同时接受脾肿大(长轴>15厘米)脾切除术患者的病历。在一家医院,除非脾脏长度>25厘米,否则行LS,而另一家医院仅采用OS。对可能适合LS的患者的人口统计学、术中及术后变量进行比较。数据以中位数(四分位间距)表示,并采用非参数检验进行分析。P<0.05被认为具有统计学意义。
两家医院共进行了65例腹腔镜和25例开放性脾切除术,其中34例为脾肿大手术。5例开放性手术涉及脾脏>25厘米,被排除在外,剩余18例LS(13例手辅助)和11例OS用于进一步分析。两组在合并症评分、脾脏长度、血液学诊断和术中失血量方面相似。开放性手术组患者更年轻,女性更多,手术时间更短。LS组患者经口进食时间(1天对2天;P=0.04)和住院时间(3天对6天;P=0.01)更短。LS组7例(39%)和OS组6例(55%)患者发生术后并发症(P=0.47);LS组3例和OS组1例发生严重并发症(P=1.0)。LS术后所有3例严重并发症均发生在3例骨髓纤维化患者中,均因出血需中转开腹或再次手术。
腹腔镜脾切除术对大多数脾脏大小在15至25厘米的脾肿大患者有益,因为其与经口进食时间更快和住院时间更短相关。腹腔镜脾切除术后的严重并发症主要与骨髓纤维化手术有关。由于出血并发症,这些患者未从腹腔镜手术中获益,需要中转或再次开腹手术。